Searchable abstracts of presentations at key conferences in endocrinology

ea0081p401 | Pituitary and Neuroendocrinology | ECE2022

Prevalence, type and evolution of autoimmune diseases with respect to hormone control in patients with cortisol, GH and prolactin hypersecretion

Guaraldi Federica , Zoli Matteo , Arvat Emanuela , De Martin Martina , Pecori Giraldi Francesca , Carla Scaroni , Gori Davide , GIORDANO Roberta , Grottoli Silvia , Ghigo Ezio , Asioli Sofia , Mazzatenta Diego

Background: In vitro and animal experiments have clearly demonstrated that excessive cortisol, GH and prolactin secretion, as well as dopamine agonists (D2As) and somatostatin analogs (SSAs), often prescribed for their treatment, affect the immune response and the onset/evolution of autoimmune diseases (AIDs) through direct and indirect complex mechanisms. Data from clinical studies are very scanty.Study aim: To assess the 1) distribution of AIDs accordi...

ea0088007 | Abstracts | BES2022

The impact of interferon-α on global gene expression in iPSC-derived β- and α-like cells

Sandra Marin-Canas , Florian Szymczak , Maria Ines Alvelos , Stephane Demine , Maikel L Colli , de Beeck Anne Op , Sofia Thomaidou , Lorella Marselli , Arnaud Zaldumbide , Piero Marchetti , Decio L Eizirik

Aim: IFNα is a key regulator of the initial dialogue between pancreatic β-cells and the immune system in type 1 diabetes (T1D). IFNα induces endoplasmic reticulum (ER) stress, insulitis and a massive HLA-ABC overexpression in human β-cells, three histological hallmarks of T1D. Against this background we investigated the global role of IFNα on iPSC-derived islet-like cells, used here to mimic islet cells in the early neonatal period when autoimmunity ag...

ea0090oc4.1 | Oral Communications 4: Reproductive and Developmental Endocrinology | ECE2023

Gender-affirming hormone treatment: friend or foe? Long term follow-up of 755 transgender and gender diverse people

Spaggiari Giorgia , Marinelli Lorenzo , Cacciani Marta , Scipio Sofia , Bichiri Andreina , Profeta Alessandra , Granata Antonio Raffaele Michele , Ghigo Ezio , Simoni Manuela , Motta Giovanna , Santi Daniele

Background: Gender-affirming hormone treatment (GAHT) is the cornerstone in the therapeutic management of transgender and gender diverse (TGD) people, which are currently classified as transgender assigned-female-at birth (t-AFAB) and assigned-male-at birth (t-AMAB) subjects. Due to its hormonal nature, GAHT is commonly handled by the endocrinologist and available guidelines on this topic mimic the recommendations for cis-gender hypogonadal populations. However, the GAHT long ...

ea0090p406 | Pituitary and Neuroendocrinology | ECE2023

Somatotroph Pituitary Neuroendocrine Tumors (Pitnets)/Adenomas Expressing Steroidogenic Factor (SF1)

Guaraldi Federica , Roncaroli Federico , Villa Chiara , Zoli Matteo , Waqar Mueez , Higham Claire , Lally Imogen , Baussart Bertrand , Assie Guillaume , Morandi Luca , Mazzatenta Diego , Asioli Sofia

Rationale and aim: A recent pangenomic study documented a subset of somatotroph mostly GNAS-wildtype PitNET/adenomas co-express steroidogenic factor 1 (SF1). Aim of our study was to investigate clinical and molecular features of a cohort of these tumour subtype. Study sample: We identified 20 cases of SF1-expressing somatotropinomas out of 173 (11.6%) operated via transsphenoidal endoscopic approach in 3 referral Pituitary Centers patients. Pre- and post...

ea0067o59 | Oral Presentations | EYES2019

Reduced insulin clearance relates to increased liver fat content in recent-onset type 2 diabetes and to impaired glucose control in recent-onset type 1 diabetes

Antoniou Sofia , Zaharia Oana P , Bobrov Pavel , Strassburger Klaus , Karusheva Yanislava , Bodis Kalman , Kupriyanova Yuliya , Burkart Volker , Hwang Jong-Hee , Mussig Karsten , Gastaldelli Amalia , Roden Michael , Szendroedi Julia

Objective: Insulin clearance can be lower in longstanding insulin-resistant states, whereas hepatic insulin kinetics are not yet clear in newly diagnosed diabetes mellitus.Methods: Volunteers with type 1 (T1D; n=276, 66% male) or type 2 diabetes (T2D; n=451, 69%) and glucose-tolerant humans (CON; n=143, 65%) underwent hyperinsulinemic-euglycemic clamps to assess whole-body insulin sensitivity (M-value) and whole-body insulin cl...

ea0063gp76 | Thyroid Autoimmune Disorders | ECE2019

Cardiovascular risk factors, autoimmunity and insulin resistance in Graves disease

Ferreira Catia Tomas , Neves Celestino , Neves Joao Sergio , Oliveira Sofia Castro , Sokhatska Oksana , Pereira Miguel , Oliveira Ana , Medina Jose Luis , Delgado Luis , Carvalho Davide

Introduction: Graves’ disease is an autoimmune disease accounting for the majority of hyperthyroidism cases.Aim: We aimed to assess the interrelationships between cardiovascular risk factors, autoimmunity, insulin resistance and treatment in Graves’ disease.Material and methods: We measured free T3 (FT3), free T4 (FT4), TSH, thyrotropin receptor antibodies (TRAb), anti-thyroglobulin and anti-TPO antibodies, thyro...

ea0063gp77 | Thyroid Autoimmune Disorders | ECE2019

Lipid profile, insulin resistance and cytokines evaluation in autoimmune thyroiditis patients

Goncalves Juliana , Neves Celestino , Pego Francisco , Neves Joao Sergio , Oliveira Sofia Castro , Sokhatska Oksana , Pereira Miguel , Oliveira Ana , Medina Jose Luis , Delgado Luis , Carvalho Davide

Introduction: Thyroid dysfunction has been associated with cardiovascular events since it worsens atherogenesis, insulin resistance and dyslipidemia. Thyroid hormones and adipokines interact with each other to regulate metabolism. The impact of thyroid dysfunction on adipokines serum levels remains controversial.Objective: To evaluate the interrelations between thyroid function and cardiovascular risk factors as insulin resistance, lipid profile, inflamm...

ea0063gp78 | Thyroid Autoimmune Disorders | ECE2019

Autoimmune thyroiditis, Graves’ disease and adiponectin, resistin and plasminogen activator inhibitor-1 levels

Neves Celestino , Neves Joao Sergio , Oliveira Sofia Castro , Sokhatska Oksana , Pereira Miguel , Oliveira Ana , Medina Jose Luis , Delgado Luis , Carvalho Davide

Introduction: The interrelationship between autoimmune thyroiditis, Graves’ disease and plasma adipokines levels remains elusive.Aims: We aimed to compare the levels of adiponectin, resistin and PAI-1 levels in patients with autoimmune thyroiditis and Graves’ disease.Subjects and methods: We recorded thyroid function tests, BMI, the levels of total cholesterol (TC), HDL, LDL-cholesterol, triglycerides (TG), apolipoprotein...

ea0063p367 | Thyroid 1 | ECE2019

Giant cystic pheochromocytoma: A clinically silent entity

Afentoulidi Aikaterini , Markogiannakis Haridimos , Kekis Panagiotis , Natoudi Maria , Gavriilidou Stavroula , Belis Constantinos , Xydiari Kalliopi , Athanasiou Vasileios , Malaktari-Skarantavou Sofia , Leandros Emmanouil , Savvidis Christos

Introduction: Pheochromocytomas (PCCs) are rare neuroendocrine catecholamine secreting-tumors derived from chromaffin cells of the adrenal medulla. PCCs are usually solid tumors but rarely occur as a cystic lesion. Cystic pheocromocytomas (CPCCs) are usually asymptomatic, unilateral and of a large size without typical radiological and biochemical features of pheochromocytomas. Non-specific abdominal pain has been reported in several cases.Case Presentati...

ea0063p401 | Thyroid 1 | ECE2019

Jejunum metastasis and perforation from anaplastic thyroid cancer

Gavriilidou Stavroula , Belis Constantinos , Afentoulidi Aikaterini , Xydiari Kalliopi , Fotou Maria , Oikonomou Vassiliki , Zoumpouli Christina , Stroumpouli Evangelia , Athanasiou Vasileios , Malaktari-Skarantavou Sofia , Savvidis Christos

Introduction: Anaplastic thyroid carcinoma (ATC) accounts for 1.7% of all thyroid cancers with poor prognosis and a median survival of 4 to 12 months. We report a case of ATC with small intestine perforation due to metastasis in the jejunum.Case report: A 57-year-old woman was referred to our department for a rapidly enlarging goiter and dyspnea. Her latest thyroid ultrasound was performed about a month ago and demonstrated 2 nodules measuring 21×16...